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Abstract
Background: The relationship between lung and joint inflammation in rheumatoid arthritis is poorly understood.
Lung inflammation with resultant protein citrullination may trigger anti-citrullinated protein antibodies, inflammation,
and arthritis. Alternatively, lung and joint inflammation may be two manifestations of a single underlying pathology.
The lung has increased citrullination and TNF-α levels are high in rheumatoid arthritis; however, it is unknown if TNF-α
can induce lung protein citrullination. The citrullinating enzyme peptidylarginine deiminase 4 (PAD4) exacerbates
TNF-α-induced arthritis, but a role for PAD4 in lung citrullination and TNF-α-induced lung inflammation has not
been explored. Our aim was to use TNF-α-overexpressing mice to clarify the intersection of TNF-α, citrullination,
PAD4, arthritis, and lung inflammation.
Methods: Lung protein citrullination in wild-type mice, mice that overexpress TNF-α systemically (TNF+), TNF+PAD4+/+,
and TNF+PAD4-/- mice was quantified by both gel electrophoresis using a citrulline probe and western blot.
Hematoxylin and eosin (H&E)-stained lung sections from TNF+PAD4+/+ and TNF+PAD4-/- mice were scored for
lung inflammation. H&E-stained ankle joint sections from mice that overexpress TNF-α only in the lungs were
assessed for arthritis.
Results: TNF+ mice have increased lung protein citrullination. TNF+PAD4-/- mice do not have significantly
reduced lung protein citrullination, but do have decreased lung inflammation compared to TNF+PAD4+/+ mice.
Mice that overexpress TNF-α only in the lungs do not develop arthritis.
Conclusions: PAD4 exacerbates lung inflammation downstream of TNF-α without having a major role in
generalized protein citrullination in inflamed lungs. Also, TNF-α-induced lung inflammation is not sufficient to
drive murine arthritis.
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Background
Over the past decade, our understanding of rheumatoid
arthritis has grown with a potential role for citrullinated
proteins and the peptidylarginine deiminases (PADs) in
disease development. Rheumatoid arthritis may start
with an environmental trigger leading to protein citrulli-
nation. Genetically susceptible individuals form anti-
citrullinated protein antibodies (ACPAs) as part of a loss
of tolerance to citrullinated and other posttranslationally
modified proteins. As inflammation increases secondary
to the loss of tolerance, the levels of inflammatory cyto-
kines such as tumor necrosis factor alpha (TNF-α) rise
and ultimately inflammatory arthritis develops.
Citrullination is a posttranslational modification cata-
lyzed by the PAD enzymes whereby arginines are con-
verted to citrullines. PAD4 is particularly interesting in
rheumatoid arthritis for several reasons. It is expressed
in immune cells and is increased in the rheumatoid joint
[1, 2]. Also, PAD4 can citrullinate proteins as part of
immune-mediated membranolytic pathways [3] and as
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part of neutrophil extracellular trap (NET) formation
[4–6], both of which have been implicated in ACPA de-
velopment. Furthermore, single nucleotide polymor-
phisms in the gene encoding PAD4 are associated with
rheumatoid arthritis [7, 8]. Therefore, PAD4 is likely
important in the pathogenesis of human rheumatoid
arthritis. Mice deficient in PAD4 have reduced TNF-α-
induced [9] and glucose-6-phosphate isomerase-induced
arthritis [10], but it is not known if PAD4 impacts lung
citrullination or inflammation.
Lung inflammation is tightly linked to rheumatoid
arthritis with clinical interstitial lung disease occurring
in about 10 % of rheumatoid arthritis patients and sub-
clinical lung disease in up to 80 % of rheumatoid arth-
ritis patients [11]. Also, people with serum ACPAs and/
or rheumatoid factor and no arthritis have twice the rate
of subclinical lung disease as people without these auto-
antibodies [12]. Finally, citrullinated proteins are found
in lungs and joints that are inflamed for a variety of rea-
sons [13–16]. Based on these observations, two hypoth-
eses emerge for how lung and joint inflammation are
linked. One possibility is that lung and joint inflamma-
tion are two independent outcomes of the same patho-
logic loss of tolerance. In this model, citrullination could
be induced in both tissues by the same factors, possibly
by TNF-α given its ability to stimulate the formation of
NETs [4]. Alternatively, lung inflammation with resultant
protein citrullination may trigger ACPA development
and ultimately rheumatoid arthritis. This latter hypoth-
esis is consistent with observations that several risk fac-
tors for rheumatoid arthritis and ACPAs are inhaled
[17, 18]. Additionally, in ACPA-positive rheumatoid
arthritis patients, ACPA levels are higher in bronchiolar
lavage fluid compared to serum, although synovial fluid
ACPA levels were not assessed [13]. One limitation to
most human studies focused on lung and joint inflam-
mation is that they are correlative. Thus, an under-
standing of how lung and joint inflammation intersect
has been elusive.
To test causality, it is often necessary to use animal
models. One good model of rheumatoid arthritis is the
TNF-α transgenic mouse, in which human TNF-α is
overexpressed systemically causing a severe inflamma-
tory and destructive arthritis that starts at 4–8 weeks of
age depending on the number of copies of the TNF-α
transgene [19, 20]. These mice also develop lung inflam-
mation since overexpression of TNF-α in the lung in-
duces a severe lung disease with alveolitis, fibrosis,
emphysematous changes, endothelial changes, and
platelet trapping [21, 22]. Given the presence of arth-
ritis as well as both airway disease and interstitial lung
disease (both of which have links to rheumatoid arth-
ritis [23, 24]) induced by TNF-α, this model is particu-
larly useful for exploring the pathophysiology of
rheumatoid arthritis and rheumatoid lung disease.
TNF-α-overexpressing mice have increased citrullina-
tion of serum proteins as well as autoantibodies that
bind native and citrullinated proteins [9], but protein
citrullination in the inflamed lungs of these mice has
not been assessed.
In this study, we employ mice that overexpress TNF-α
to determine if TNF-α can induce lung citrullination, if
PAD4 is required for lung citrullination and/or lung in-
flammation downstream of TNF-α, and if TNF-α-induced
lung inflammation is sufficient to induce arthritis.
Methods
Animals
Mice that overexpress systemically one copy of the TNF-
α transgene (Tg3647 transgenic mice referred to here as
TNF+ [19]) were crossed with PAD4-deficient mice [5]
to generate TNF+PAD4+/+ and TNF+PAD4-/- mice. Lit-
termates were used for all experiments. Mice that over-
express TNF-α only in the lungs under the control of
the surfactant promoter [21] and wild-type littermates
were allowed to age 85–94 weeks.
Protein lysates
Lung tissue was harvested from mice, flash frozen and
homogenized using a Bullet Blender (Next Advance,
Averill Park, NY, USA) in RIPA buffer supplemented
with protease inhibitor cocktail (Sigma-Aldrich, St.
Louis, MO, USA). Lysates were sonicated briefly and
total protein was quantified.
Detection of citrullination with rhodamine-phenylglyoxal
(Rh-PG)
Equal amounts of protein were diluted with trichloroacetic
acid and incubated with Rh-PG as previously described [25].
The reaction was quenched with L-citrulline, washed with
acetone, and resuspended in 2× SDS loading dye for gel
electrophoresis. Gels were imaged (excitation 532 nm, emis-
sion 580 nm) using an ImageQuant LAS 4000 (GE Health-
care Life Sciences, Chicago, IL, USA), stained with brilliant
blue G – colloidal solution (Sigma-Aldrich, St. Louis, MO,
USA) and re-imaged using a LI-COR Odyssey infrared scan-
ner (LI-COR Biosciences, Lincoln, NE, USA). Full lane
densitometry for Rh-PG and brilliant blue was performed.
Detection of citrullination by western blot
Equal amounts of protein were subjected to gel electro-
phoresis using two polyacrylamide gels. One gel was
stained with brilliant blue and the other was transferred to
a polyvinylidene difluoride membrane (Bio-Rad, Hercules,
CA, USA) using a semi-dry blotting system (Bio-Rad,
Hercules, CA, USA). The membrane was blocked with
milk, incubated overnight at 4 °C in 1:1000 mouse mono-
clonal anti-peptidyl citrulline (F95) antibody [26] in milk,
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washed, incubated with a 1:10,000 dilution of anti-mouse
IgM conjugated to IRDye 680LT (LI-COR Biosciences,
Lincoln, NE, USA) for 1 hour at room temperature,
washed, and imaged using the Odyssey infrared scanner
followed by whole lane densitometry. Findings are un-
changed when densitometry is performed excluding bands
that are the same size as those seen using anti-mouse IgM
alone.
Pathology
Lungs and hind legs were fixed in 10 % neutral-buffered
formalin, processed with a VIP processor, embedded in
paraffin (Tissue Tek, Sakura, Torrance, CA, USA), sec-
tioned and stained with hematoxylin and eosin (H&E).
Hind legs were decalcified for 30 hours with Surgipath
Decalcifier 1 (Leica Biosystems, Wetzlar, Germany) prior
to processing and embedding. Lung disease was scored
in a blinded manner by a board-certified pathologist on
a scale of 0–5 (0, none; 1, mild; 2, mild to moderate; 3,
moderate; 4, moderate to severe; 5, severe) for the fol-
lowing characteristics: lymphocytic parabronchiolar foci,
perivascular lymphoid infiltrates, destructive vasculitis,
interstitial inflammatory infiltrates, and alveolar infil-
trates. Scores were not limited to integer values. Ankle
joints were evaluated for synovitis and erosions in a
blinded manner by a board-certified pathologist.
Statistics
All data were analyzed using a t test with the results
considered significant if the two-tailed p value was less
than 0.05.
Results
TNF-α induces lung citrullination
To quantify protein citrullination, we allowed a
citrulline-specific, fluorescently labeled chemical probe,
Rh-PG [25], to bind to protein followed by gel electro-
phoresis to visualize the Rh-PG-bound protein. After
confirming increased Rh-PG binding to in vitro citrulli-
nated fibronectin [27] compared to native fibronectin
(see Additional file 1), we used Rh-PG to assess citrulli-
nation in lung lysates from 5-month-old mice that over-
express TNF-α systemically (TNF+ mice) and wild-type
littermates. As shown in Fig. 1a and b, there is increased
total protein citrullination in lung lysates from TNF+
compared to wild-type mice. No significant increase in
protein citrullination is seen in TNF+ compared to wild-
type mice at 2 and 3.5 months of age (data not shown).
Although normal lungs have some baseline PAD activ-
ity [28] and native fibronectin may have some baseline
citrullination, we were concerned about potential back-
ground signal using Rh-PG. Further, Rh-PG detects car-
bamylated proteins reducing its specificity. Thus, we
repeated our experiments using a monoclonal anti-
peptidyl-citrulline antibody (F95) to detect citrullinated
protein by western blot [26]. First, we confirmed in-
creased binding of F95 to citrullinated fibronectin as
compared to native fibronectin by western blot (see
Additional file 1). Then, we used F95 to assess protein
citrullination in the lungs of TNF+ and control mice by
western blot. As shown in Fig. 1c and d, TNF+ mice have
increased lung protein citrullination compared to wild-
type littermates at 5 months of age. No significant in-
crease in citrullination was seen at 2 and 3.5 months of
age in TNF+ mice using F95 (data not shown). Taken to-
gether, our data suggest that TNF-α induces citrullina-
tion in murine lungs.
PAD4 is not required for lung citrullination in TNF+ mice
After demonstrating that lung citrullination is increased
in TNF+ mice, we wanted to determine if the citrullina-
tion seen might require PAD4. Therefore, we used Rh-
PG as above to quantify protein citrullination in lung
protein lysates from 5-month-old TNF+PAD4+/+ and
TNF+PAD4-/- mice. We did not detect a reduction in
total protein citrullination in the lung (Fig. 2a and b) in
TNF+PAD4-/- mice compared to TNF+PAD4+/+ mice. To
support these results, we performed western blots on
lung lysates as above using F95. In agreement with the
Rh-PG results, we saw no significant reduction in total
protein citrullination in the lung in TNF+PAD4-/- mice
compared to TNF+PAD4+/+ mice (Fig. 2c and d). Similar
results were seen in the lungs of TNF+PAD4-/- and
TNF+PAD4+/+ mice at 2 and 3.5 months of age using
both methods (data not shown). Also, we did not detect
a significant reduction in citrullination of specific pro-
tein bands in TNF+PAD4-/- compared to TNF+PAD4+/+
mice (data not shown). These data suggest that PAD4
is not critical for gross protein citrullination in TNF+
mice.
PAD4 contributes to TNF-α-induced lung inflammation
Despite our observation that PAD4 is not critical for
total lung citrullination in TNF+ mice, we hypothesized
that PAD4 might be important for TNF-α-induced lung
inflammation since it contributes to TNF-α-induced
joint inflammation [9]. To test this hypothesis, H&E
sections from the lungs of 2-, 3.5-, and 5-month-old
TNF+PAD4+/+ and TNF+PAD4-/- mice were scored for
the severity of lung disease in a blinded manner. At
3.5 months of age, TNF+PAD4-/- mice have reduced
perivascular lymphoid infiltrates and interstitial infil-
trates compared to TNF+PAD4+/+ mice (Fig. 3). The se-
verity of both perivascular and interstitial infiltrates
increases at 5 months of age and the difference be-
tween TNF+PAD4+/+ and TNF+PAD4-/- mice disap-
pears. However, by 5 months of age, a destructive
vasculitis becomes prominent and this vasculitis is
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reduced in TNF+PAD4-/- compared to TNF+PAD4+/+
mice (Fig. 4a and b). Five-month-old controls that do
not overexpress TNF-α (TNF-PAD4+/+) show no in-
flammatory infiltrates or destructive vasculitis (Fig. 4c).
There was no difference between TNF+PAD4+/+ and
TNF+PAD4-/- mice with regards to parabronchiolar in-
flammation or alveolar infiltrates at any age (data not
shown). Taken together, these data suggest that PAD4
contributes to interstitial and perivascular inflamma-
tion as well as destructive vasculitis downstream of
TNF-α in murine lungs.
TNF-α overexpression in the lung is not sufficient to
induce arthritis in mice
Since TNF-α induces protein citrullination in the lung,
which is thought to be a potential trigger for rheumatoid
arthritis, we hypothesized that TNF-α-induced lung in-
flammation might induce arthritis development. There-
fore, we harvested the joints from almost 2-year-old
mice that overexpress TNF-α only in the lungs under
the control of the surfactant promoter [21]. We pre-
pared H&E sections and then evaluated for the presence
of arthritis in a blinded manner. None of the mice that
overexpress TNF-α only in the lung had any arthritis by
histology similar to wild-type controls (Fig. 5). Thus
TNF-α-driven lung disease is not sufficient to induce in-
flammatory arthritis in mice.
Discussion
In the present study, we show that overexpression of
TNF-α, a major pathologic cytokine in rheumatoid arth-
ritis, induces murine lung citrullination providing evi-
dence for a pathway by which lung citrullination may be
induced in human disease. In human rheumatoid arth-
ritis, high levels of TNF-α may be a trigger for the ob-
served citrullination in the rheumatoid lung [16]. The
presence of citrullinated proteins in the lung down-
stream of TNF-α may provide fodder for inflammation,
Fig. 1 TNF-α induces lung citrullination. Lung protein lysates from TNF-α overexpressing (TNF) and control (WT) mice were exposed to Rh-PG
followed by gel electrophoresis, imaging of Rh-PG, then staining with brilliant blue to detect total protein. a Representative gels. b Total Rh-PG
signal was normalized to total protein with average and SEM graphed. Lysates were subjected to western blot using the F95 antibody to detect
citrullinated proteins and gel electrophoresis with brilliant blue to detect total protein. c Representative western blot (left) and brilliant blue-stained gel
(right). d Total F95 signal was normalized to total protein with average and SEM graphed. For all panels, n = 5 TNF and 6 WT, *p < 0.05 TNF-α tumor
necrosis factor alpha, WT wild-type
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particularly in ACPA-positive individuals, thus contrib-
uting to ongoing disease.
Despite our observation that TNF-α induces lung
citrullination, we found that TNF-α-driven lung inflam-
mation is not sufficient to induce arthritis. Our work
builds on previous studies, which found that chronic ex-
posure to tobacco smoke or intratracheal bleomycin is
not sufficient to drive arthritis in SKG mice [29], a mur-
ine line that develops lung and joint inflammation upon
exposure to microbial products [30, 31]. Taken together,
these studies do not support a model in which lung in-
flammation independently induces joint inflammation.
Rather, joint inflammation and lung inflammation ap-
pear to be two manifestations of a single pathologic
process. In the case of our experiments, the pathologic
process is high levels of TNF-α, which is also seen in
rheumatoid arthritis.
The same mechanism may be true in humans. Once
tolerance is lost, increasing levels of inflammatory cyto-
kines like TNF-α in the preclinical phase of rheumatoid
arthritis may drive both joint and lung inflammation. It
is known that cytokines rise prior to the onset of arth-
ritis [32], but less is known about the chronology of
cytokine levels and lung inflammation. However, one
cannot simply translate murine findings to human
rheumatoid arthritis for several reasons. First, there are
genetic differences between humans and mice, particu-
larly in the major histocompatibility complex (MHC)
class II locus. Specific MHC class II variants are closely
associated with ACPAs and rheumatoid arthritis [33]
and bind citrullinated peptides better than native pep-
tides [34]. The absence of specific MHC variants may
explain the absence of autoantibodies that uniquely tar-
get citrullinated antigens in mice that overexpress TNF-
α [9] as well as possibly the inability for TNF-α-induced
lung inflammation to independently drive murine arth-
ritis. Also, humans may have exposure to decades of
lung inflammation or “second hits” such as smoking,
minor joint trauma, or infections that could drive arth-
ritis, none of which our mice experience. Thus, it is pos-
sible that the lung could play an inciting role and also be
a target organ in human rheumatoid arthritis. However,
our data only support the role of the lung as a target
and not as an initiator of arthritis.
We have also found that PAD4 does not play a major
role in lung citrullination in TNF+ mice. This result is
surprising given previous studies that show a relation-
ship between TNF-α, nuclear localization of PAD4,
citrullination, and rheumatoid arthritis [14, 35–37].
However, we used two different methods to assess pro-
tein citrullination, which gave similar results. Also, our
findings are in agreement with previous work showing
that PAD4 is not required for citrullination of serum
proteins in TNF+ mice as detected by a colorimetric
assay [9]. Thus, although PAD4 is capable of citrullinat-
ing proteins, it does not appear to be required for a large
portion of lung protein citrullination downstream of
TNF-α. It is possible that PAD4 is required for the
citrullination of a small number of proteins or specific
arginines in a protein [38], but gross protein citrullina-
tion in the lungs of TNF+ mice, which is similarly seen
in the rheumatoid lung [16], is not critically dependent
on PAD4. Thus, it is likely that other PAD enzymes,
such as PAD2, are responsible for total lung citrullina-
tion downstream of TNF-α. Like PAD4, PAD2 is
expressed in immune cells [2, 38]. Further, PAD2 is in-
creased in the lungs of smokers [39, 40] and the synovial
fluid of ACPA-positive rheumatoid arthritis patients
[41]. PAD2 is also required for baseline PAD activity in
non-inflamed lungs [28]. Further studies are needed to
determine if PAD2 is required for TNF-α-induced
citrullination.
We have also shown that PAD4 is important for TNF-
α-driven lung inflammation in agreement with previous
Fig. 2 PAD4 is not required for TNF-α-driven lung citrullination. Lung
lysates from TNF+PAD4+/+ and TNF+PAD4-/- mice were exposed to Rh-PG,
followed by gel electrophoresis, imaging of Rh-PG, then staining with
brilliant blue to detect total protein. a Representative gels. b Total Rh-PG
signal was normalized to total protein with average and SEM graphed.
Lysates were subjected to western blot using the F95 antibody to detect
citrullinated proteins and gel electrophoresis with brilliant blue to
detect total protein. c Representative western blot (left) and brilliant
blue-stained gel (right). d Total F95 signal was normalized to total
protein with average and SEM graphed. For all panels, n = 9 littermate
pairs. PAD4 peptidylarginine deiminase 4, TNF-α tumor necrosis
factor alpha
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Fig. 3 PAD4 contributes to inflammatory infiltrates in TNF-α-driven lung inflammation. H&E-stained lung sections from 2-, 3.5-, and 5-month-old
TNF+PAD4+/+ and TNF+PAD4-/- littermates were scored for the severity of perivascular infiltrates and interstitial infiltrates. a Representative images
of TNF+PAD4+/+ and TNF+PAD4-/- lungs at 3.5 months of age (200×, bar 0.1 mm). Arrows indicate representative perivascular lymphoid infiltrates.
Average and SEM for severity of perivascular infiltrates (b) and interstitial infiltrates (c) are shown (2 months old: n = 5 littermate pairs, 3.5 months
old: n = 6 TNF+PAD4+/+ and 7 TNF+PAD4-/- mice, 5 months old: n = 10 TNF+PAD4+/+ and 11 TNF+PAD4-/- mice; *p < 0.05). PAD4 peptidylarginine
deiminase 4, TNF-α tumor necrosis factor alpha
Fig. 4 PAD4 contributes to vasculitis in TNF-α-driven lung inflammation. H&E-stained lung sections from 2-, 3.5-, and 5-month-old TNF+PAD4+/+
and TNF+PAD4-/- littermates were scored for the severity of destructive vasculitis. a Representative images of TNF+PAD4+/+ and TNF+PAD4-/- lungs
at 5 months of age. Arrows point to vessels with representative amounts of destructive vasculitis. b Average and SEM for severity of destructive
vasculitis are shown (2 months old: n = 5 littermate pairs, 3.5 months old: n = 6 TNF+PAD4+/+ and 7 TNF+PAD4-/- mice, 5 months old: n = 10 TNF+PAD4+/+
and 11 TNF+PAD4-/- mice, *p< 0.05). c Five-month-old wild-type littermate lung. Arrow points to representative normal vessel. All images: 200×, bar
0.1 mm. PAD4 peptidylarginine deiminase 4, TNF-α tumor necrosis factor alpha
Bawadekar et al. Arthritis Research & Therapy  (2016) 18:173 Page 6 of 9
findings that PAD4 contributes to TNF-α-driven joint
inflammation [9]. Initially PAD4 contributes to perivas-
cular and interstitial inflammatory infiltrates and later to
destructive vasculitis in the lung. Of note, patients with
rheumatoid arthritis can develop a systemic vasculitis.
Our findings suggest that PAD4 could contribute to
rheumatoid vasculitis, which would be consistent with
observations that PAD4 and NETs may be involved in
other forms of vasculitis [42, 43].
Our finding that PAD4 significantly contributes to
lung inflammation, but not total protein citrullination
in the lung, supports a role for PAD4 apart from mass
antigen citrullination. This role is likely multifactorial
since, in addition to a role for PAD4 in neutrophils,
PAD4 is expressed in monocytes and macrophages [2]
and it contributes to the presence of activated T cells
(including Th17 cells) and total immunoglobulin levels
in murine inflammatory arthritis [9, 10]. Further, treat-
ment with PAD inhibitors reduces inflammatory cyto-
kine production by HL60 cells [44] and induces
apoptosis in lymphoid cells [45]. The observed reduction
in perivascular lymphoid infiltrates in TNF+PAD4-/-
lungs points to a role for PAD4 in the lymphoid
compartment, although we cannot conclude if PAD4 is
required in lymphocytes or in cells that regulate lym-
phocytes. PAD4 may have large effects on immune cells
while citrullinating only a few total arginines. Such a
small amount of citrullination would likely not be de-
tected with our methods. Nonetheless, PAD4 appears
to contribute to inflammation independently of gross
citrullination. Additional studies are needed to better
characterize the role of PAD4 in immune cells, clarify
the role of PAD2 in citrullination and arthritis, and
determine how both PADs contribute to human
rheumatoid arthritis.
Conclusions
We have shown that PAD4 contributes to lung inflam-
mation, but is not critical for gross protein citrullina-
tion in the inflamed lung. These findings suggest that
PAD4 exacerbates inflammation apart from antigen
citrullination and that PADs other than PAD4 are re-
sponsible for the majority of inflammation-dependent
protein citrullination in the lung. Further, we have
shown that TNF-α-induced lung inflammation is not
sufficient to cause murine arthritis, suggesting that lung
and joint inflammation are two separate outcomes of a
single underlying pathologic process instead of lung in-
flammation driving murine inflammatory arthritis. Fur-
ther work is needed to extrapolate these findings to
human rheumatoid arthritis.
Additional file
Additional file 1: Figure S1. Increased Rh-PG and F95 binding to
citrullinated fibronectin. Fibronectin purified from human blood was
citrullinated in vitro as previously described [27]. Native (FN) and citrullinated
(cit-FN) fibronectin were exposed to Rh-PG followed by gel electrophoresis,
imaging of Rh-PG, and staining with brilliant blue to detect total protein. a
Representative gels. b Average and SEM are graphed for total Rh-PG signal
normalized to total protein. FN and cit-FN were subjected to western blot
using the F95 antibody and gel electrophoresis with brilliant blue to detect
total protein. c Representative blot (upper) and gel (lower). d Average and
SEM are graphed for total F95 signal normalized to total protein. For all
panels, n = 3 experiments, **p < 0.01, ***p < 0.001. (PDF 1349 kb)
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